Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedMar 01, 2026
DataAggregated Company Financials
Companies5
  • 7D-1.5%
  • 3M-12.2%
  • 1Y-2.7%
  • YTD-9.5%

Over the last 7 days, the Biotech industry has dropped 1.5%, driven by a pullback from Zealand Pharma of 7.4%. Over the last year, the industry has been flat overall. In the next few years, earnings are forecast to decline by 2.0% annually.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 01 Mar 2026DKK 155.3bDKK 39.7bDKK 14.9b6.3x10.4x3.9x
Tue, 27 Jan 2026DKK 175.5bDKK 40.2bDKK 18.8b6.4x9.3x4.4x
Thu, 25 Dec 2025DKK 180.1bDKK 40.5bDKK 18.9b6.1x9.5x4.5x
Sat, 22 Nov 2025DKK 172.7bDKK 41.0bDKK 19.2b5.9x9x4.2x
Mon, 20 Oct 2025DKK 180.0bDKK 38.9bDKK 16.8b13.1x10.7x4.6x
Wed, 17 Sep 2025DKK 158.1bDKK 38.6bDKK 16.6b12.7x9.5x4.1x
Fri, 15 Aug 2025DKK 133.8bDKK 38.7bDKK 16.7b10.2x8x3.5x
Sun, 13 Jul 2025DKK 125.5bDKK 26.9bDKK 7.3b11.1x17.1x4.7x
Tue, 10 Jun 2025DKK 137.5bDKK 27.5bDKK 7.5b11.3x18.3x5x
Thu, 08 May 2025DKK 129.4bDKK 27.3bDKK 7.7b11.5x16.8x4.7x
Sat, 05 Apr 2025DKK 121.4bDKK 27.3bDKK 7.7b10.7x15.8x4.4x
Mon, 03 Mar 2025DKK 162.8bDKK 27.7bDKK 7.8b12.4x20.8x5.9x
Wed, 29 Jan 2025DKK 165.8bDKK 26.0bDKK 4.7b16.1x35.3x6.4x
Fri, 27 Dec 2024DKK 160.6bDKK 26.0bDKK 4.7b16.6x34.2x6.2x
Sun, 24 Nov 2024DKK 161.9bDKK 26.0bDKK 4.7b17x34.5x6.2x
Tue, 22 Oct 2024DKK 174.1bDKK 25.5bDKK 5.5b20.9x31.8x6.8x
Thu, 19 Sep 2024DKK 195.2bDKK 25.5bDKK 5.5b23.6x35.7x7.7x
Sat, 17 Aug 2024DKK 206.7bDKK 26.1bDKK 5.7b21.7x36x7.9x
Mon, 15 Jul 2024DKK 197.3bDKK 24.8bDKK 5.6b17.7x35x8x
Wed, 12 Jun 2024DKK 176.0bDKK 24.8bDKK 5.6b17.9x31.2x7.1x
Fri, 10 May 2024DKK 183.7bDKK 25.2bDKK 6.2b16.1x29.8x7.3x
Sun, 07 Apr 2024DKK 186.1bDKK 23.9bDKK 5.0b19.4x36.9x7.8x
Tue, 05 Mar 2024DKK 181.0bDKK 22.8bDKK 4.3b22.8x42.3x8x
Thu, 01 Feb 2024DKK 168.1bDKK 23.3bDKK 4.2b23.2x40.4x7.2x
Sat, 30 Dec 2023DKK 177.2bDKK 23.3bDKK 4.2b25.9x42.6x7.6x
Mon, 27 Nov 2023DKK 172.7bDKK 23.3bDKK 4.2b25x41.5x7.4x
Wed, 25 Oct 2023DKK 163.5bDKK 22.0bDKK 4.7b19x34.5x7.4x
Fri, 22 Sep 2023DKK 197.1bDKK 22.0bDKK 4.7b23.2x41.6x8.9x
Sun, 20 Aug 2023DKK 187.2bDKK 20.6bDKK 3.9b35.3x47.4x9.1x
Tue, 18 Jul 2023DKK 205.0bDKK 19.5bDKK 4.4b41.3x46.5x10.5x
Thu, 15 Jun 2023DKK 207.4bDKK 19.5bDKK 4.4b44.5x47.1x10.6x
Sat, 13 May 2023DKK 218.9bDKK 17.9bDKK 4.1b33.9x53.5x12.2x
Mon, 10 Apr 2023DKK 199.2bDKK 17.9bDKK 3.5b31x56.3x11.1x
Wed, 08 Mar 2023DKK 194.5bDKK 17.9bDKK 3.5b29.9x54.9x10.9x
Price to Earnings Ratio

54.9x


Total Market Cap: DKK 194.5bTotal Earnings: DKK 3.5bTotal Revenue: DKK 17.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 30.9x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 10.4x which is lower than its 3-year average PE of 30.9x.
  • The 3-year average PS ratio of 6.9x is higher than the industry's current PS ratio of 3.9x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 61% per year over the last three years.
  • Revenues for these companies have grown 30% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market-7.96%
Healthcare-15.66%
Biotech-1.50%
Biotech-1.50%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BAVA Bavarian NordicDKK 197.500.2%
+DKK 23.3m		17.5%PE6.3x
STRAP Strategic PartnersDKK 624.004.0%
+DKK 1.0m		-24.4%PB1.4x

Latest News

ZEAL
DKK 363.80
Zealand Pharma
7D
-7.4%
1Y
-45.1%

ZEAL: Positive Immunology Data And Metabolic Partnership Will Support Future Upside

Analysts have trimmed their price target on Zealand Pharma by DKK 5 to reflect updated assumptions for revenue growth, profit margins and a higher forward P/E. They have kept the overall discount rate broadly in line with prior views.
GMAB
DKK 1,848.50
Genmab
7D
-0.3%
1Y
14.9%
BAVA
DKK 197.50
Bavarian Nordic
7D
0.2%
1Y
17.5%

BAVA: Share Buybacks And Latin America Vaccine Deal Will Support Upside

Analysts now keep their DKK 250 price target for Bavarian Nordic intact, as slightly higher discount and future P/E assumptions together with a modestly stronger profit margin view offset softer revenue growth expectations. What's in the News Bavarian Nordic issued earnings guidance for fiscal 2026, indicating expected revenue in the range of DKK 5,000 million to DKK 5,200 million (Corporate guidance).
BIOPOR
DKK 0.91
BioPorto
7D
-5.5%
1Y
-39.7%
STRAP
DKK 624.00
Strategic Partners
7D
4.0%
1Y
-24.4%